✦ LIBER ✦

Protein C as a surrogate end-point for clinical trials of sepsis

✍ Scribed by Kathleen D Liu,Michael A Matthay

Book ID: 126388536
Publisher: Springer (Biomed Central Ltd.)
Year: 2008
Tongue: English
Weight: 39 KB
Volume: 12
Category: Article
ISSN: 1466-609X
DOI: 10.1186/cc6859

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Blood in the stomach as a surrogate for

Blood in the stomach as a surrogate for clinical end points in GI bleeding trials

✍ GM Hawkey; WA Stack; AT Cole; RG Long; RFA Logan; CJ Hawkey 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 165 KB

Prostate-Specific Antigen (PSA) as a Sur

Prostate-Specific Antigen (PSA) as a Surrogate End Point for Survival in Prostate Cancer Clinical Trials

✍ Laurence Collette 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 88 KB

Atheroma Volume by Intravascular Ultraso

Atheroma Volume by Intravascular Ultrasound as a Surrogate for Clinical End Points

✍ Jonathan M. Tobis; Alice Perlowski 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 127 KB

Definitions of Periprocedural Myocardial

Definitions of Periprocedural Myocardial Infarction as Surrogates for Catheterization Laboratory Quality or Clinical Trial End Points

✍ Baker, Nevin C.; Lipinski, Michael J.; Escarcega, Ricardo O.; Magalhaes, Marco A 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 453 KB

Clinical exacerbations as a surrogate en

Clinical exacerbations as a surrogate end point in heart failure research

✍ Steven L. Sayers; Barbara Riegel; Lee R. Goldberg; James C. Coyne; Frederick F. 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 146 KB

Quantitative liver function tests as sur

Quantitative liver function tests as surrogate markers for end-points in controlled clinical trials: A retrospective feasibility study

✍ E Lotterer; J Hogel; W Gaus; W E Fleig; J Bircher 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 215 KB

and nonabstinent patients with alcoholic liver disease investigated in this study, such numbers could serve for the planning Quantitative liver function tests such as the determination of controlled clinical trials, in which the control group is likely to deteriorate and the treated group is expecte